Literature DB >> 11818962

Efficient generation and mapping of recessive developmental mutations using ENU mutagenesis.

Bruce J Herron1, Weining Lu, Cherie Rao, Shanming Liu, Heiko Peters, Roderick T Bronson, Monica J Justice, J David McDonald, David R Beier.   

Abstract

Treatment with N-ethyl-N-nitrosourea (ENU) efficiently generates single-nucleotide mutations in mice. Along with the renewed interest in this approach, much attention has been given recently to large screens with broad aims; however, more finely focused studies have proven very productive as well. Here we show how mutagenesis together with genetic mapping can facilitate the rapid characterization of recessive loci required for normal embryonic development. We screened third-generation progeny of mutagenized mice at embryonic day (E) 18.5 for abnormalities of organogenesis. We ascertained 15 monogenic mutations in the 54 families that were comprehensively analyzed. We carried out the experiment as an outcross, which facilitated the genetic mapping of the mutations by haplotype analysis. We mapped seven of the mutations and identified the affected locus in two lines. Using a hierarchical approach, it is possible to maximize the efficiency of this analysis so that it can be carried out easily with modest infrastructure and resources.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11818962     DOI: 10.1038/ng812

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  86 in total

1.  Coupled mutagenesis screens and genetic mapping in zebrafish.

Authors:  John F Rawls; Matthew R Frieda; Anthony R McAdow; Jason P Gross; Chad M Clayton; Candy K Heyen; Stephen L Johnson
Journal:  Genetics       Date:  2003-03       Impact factor: 4.562

2.  Focusing forward genetics: a tripartite ENU screen for neurodevelopmental mutations in the mouse.

Authors:  R W Stottmann; J L Moran; A Turbe-Doan; E Driver; M Kelley; D R Beier
Journal:  Genetics       Date:  2011-04-21       Impact factor: 4.562

3.  Modifier screens in the mouse: time to move forward with reverse genetics.

Authors:  David J Curtis
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-05       Impact factor: 11.205

4.  Effect of PKD1 gene missense mutations on polycystin-1 membrane topogenesis.

Authors:  Nancy M Nims; Dianne Vassmer; Robin L Maser
Journal:  Biochemistry       Date:  2010-12-29       Impact factor: 3.162

5.  Assessment of a systematic expression profiling approach in ENU-induced mouse mutant lines.

Authors:  Matthias Seltmann; Marion Horsch; Alexei Drobyshev; Yali Chen; Martin Hrabé de Angelis; Johannes Beckers
Journal:  Mamm Genome       Date:  2005-01       Impact factor: 2.957

Review 6.  N-ethyl-N-nitrosourea mutagenesis: boarding the mouse mutant express.

Authors:  Sabine P Cordes
Journal:  Microbiol Mol Biol Rev       Date:  2005-09       Impact factor: 11.056

Review 7.  Orofacial clefting: recent insights into a complex trait.

Authors:  Astanand Jugessur; Jeffrey C Murray
Journal:  Curr Opin Genet Dev       Date:  2005-06       Impact factor: 5.578

8.  Prdm16 is required for normal palatogenesis in mice.

Authors:  Bryan C Bjork; Annick Turbe-Doan; Mary Prysak; Bruce J Herron; David R Beier
Journal:  Hum Mol Genet       Date:  2009-12-11       Impact factor: 6.150

9.  Analysis of mouse embryonic patterning and morphogenesis by forward genetics.

Authors:  María J García-García; Jonathan T Eggenschwiler; Tamara Caspary; Heather L Alcorn; Michael R Wyler; Danwei Huangfu; Andrew S Rakeman; Jeffrey D Lee; Evan H Feinberg; John R Timmer; Kathryn V Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-08       Impact factor: 11.205

10.  Lethal skeletal dysplasia in mice and humans lacking the golgin GMAP-210.

Authors:  Patrick Smits; Andrew D Bolton; Vincent Funari; Minh Hong; Eric D Boyden; Lei Lu; Danielle K Manning; Noelle D Dwyer; Jennifer L Moran; Mary Prysak; Barry Merriman; Stanley F Nelson; Luisa Bonafé; Andrea Superti-Furga; Shiro Ikegawa; Deborah Krakow; Daniel H Cohn; Tom Kirchhausen; Matthew L Warman; David R Beier
Journal:  N Engl J Med       Date:  2010-01-21       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.